GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Brighthouse Financial Inc (NAS:BHF) » Definitions » Research & Development

Brighthouse Financial (Brighthouse Financial) Research & Development : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Brighthouse Financial Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Brighthouse Financial's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Brighthouse Financial Research & Development Historical Data

The historical data trend for Brighthouse Financial's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brighthouse Financial Research & Development Chart

Brighthouse Financial Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Brighthouse Financial Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Brighthouse Financial Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brighthouse Financial  (NAS:BHF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Brighthouse Financial Research & Development Related Terms

Thank you for viewing the detailed overview of Brighthouse Financial's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Brighthouse Financial (Brighthouse Financial) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Brighthouse Financial Inc (NAS:BHF) » Definitions » Research & Development
Comparable Companies
JXN GNW CNO LNC FG AEL NWLI ABL KCLI VERY SHSE:601628 SHSE:601318 HKSE:01299 BOM:543526 AFL MET PRU SHSE:601601 TSX:MFC LSE:PRU
Traded in Other Exchanges
BHFAM.PFD:USA BHFAN.PFD:USA BHFAO.PFD:USA BHFAP.PFD:USA
Address
11225 North Community House Road, Gragg Building, Charlotte, NC, USA, 28277
Website
https://www.brighthousefinancial.com
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, and Run-off. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked and income annuities. The life segment includes variable, term, universal and whole life policies.
Executives
Philip V Bancroft director
Allie Lin officer: EVP & General Counsel 11225 N COMMUNITY HOUSE RD, CHARLOTTE NC 28277
Carol Juel director 777 LONG RIDGE ROAD, C/O CORPORATE SECRETARY, STAMFORD CT 06902
Kristine Toscano officer: Chief Accounting Officer 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
Vonda Huss officer: EVP, Chief HR Officer 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
Stephen C Hooley director 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Patrick J. Shouvlin director 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
William Francis Wallace director 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
Edward A. Spehar officer: EVP & Chief Financial Officer 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
Christine M. Debiase officer: EVP,Chief LegalOfficer&CorpSec 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
C Edward Chaplin director C/O MBIA, 113 KING STREET, ARMONK NY 10504
Eric T Steigerwalt director, officer: President and CEO 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
John Rosenthal officer: EVP & Chief Investment Officer 334 MADISON AVENUE, MORRISTOWN NJ 07960
Myles Lambert officer: EVP,Chief Dist. & Mktg.Officer 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
Murphy Conor officer: Chief Product&Strategy Officer 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 11225